Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Leo, Segelmark"'
Publikováno v:
Rheumatology. 61:205-212
Objectives Rituximab (RTX) is an anti-CD20 antibody that selectively depletes B cells and has emerged as a therapy for ANCA-associated vasculitis (AAV) during the past decade. This study sought to quantify and determine potential risk factors for sev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50049dc210f6a0857a956db295e45172
https://doi.org/10.1093/rheumatology/keab293
https://doi.org/10.1093/rheumatology/keab293
Autor:
Mårten, Segelmark, Leo, Segelmark, Jessica, Smolander, Helena, Rydell, Marie, Evans, Maria, Stendahl
Publikováno v:
Lakartidningen. 118
Data from the Swedish Renal Registry (SRR) show that during the period March 16, 2020 to March 15, 2021 0.4% of all renal transplant recipients and 3% of all dialysis patients died due to COVID-19 in Sweden. Of all registered deaths, 20% were attribu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4ce0cab7a7fa32d7a675cf33b3ca7f0f
https://pubmed.ncbi.nlm.nih.gov/35502607
https://pubmed.ncbi.nlm.nih.gov/35502607
Publikováno v:
Rheumatology. 58
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d49f330d44d4e4234c181382662823fc
https://doi.org/10.1093/rheumatology/kez062.045
https://doi.org/10.1093/rheumatology/kez062.045
Autor:
Leo, Segelmark
Publikováno v:
Lakartidningen. 114
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::915f1014dea8566dd2c786bc29236862
https://pubmed.ncbi.nlm.nih.gov/28994856
https://pubmed.ncbi.nlm.nih.gov/28994856